Medicago said a Phase 2 clinical trial involving hundreds of participants found the vaccine appears to produce 10 times the antibodies as are seen in people who have had COVID-19. Source

JOIN NCOV.LINK NEWSLETTER

And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.